Quality of Life

Whittaker, H. R., Torkpour, A., & Quint, J. (2024). Eligibility of patients with chronic obstructive pulmonary disease for inclusion in randomised control trials investigating triple therapy: a study using routinely collected data. Respir Res, 25, 43. http://doi.org/10.1186/s12931-024-02672-x
Voss, E. A., Ali, S. R., Singh, A., Rijnbeek, P. R., Schuemie, M. J., & Fife, D. (2022). Hip Fracture Risk After Treatment with Tramadol or Codeine: An Observational Study. Drug Saf, 45, 791-807. http://doi.org/10.1007/s40264-022-01198-9
Galvain, T., Mantel, J., Kakade, O., & Board, T. N. (2022). Treatment patterns and clinical and economic burden of hip dislocation following primary total hip arthroplasty in England. Bone Joint J, 104-b, 811-819. http://doi.org/10.1302/0301-620x.104b7.bjj-2021-1732.r1
Haroon, S., Nirantharakumar, K., Hughes, S. E., Subramanian, A., Aiyegbusi, O. L., Davies, E. H., et al. (2022). Therapies for Long COVID in non-hospitalised individuals: from symptoms, patient-reported outcomes and immunology to targeted therapies (The TLC Study). Bmj Open, 12, e060413. http://doi.org/10.1136/bmjopen-2021-060413
Ferguson, R., Prieto-Alhambra, D., Peat, G., Delmestri, A., Jordan, K. P., . Y. Strauss, V., et al. (2021). Does pre-existing morbidity influences risks and benefits of total hip replacement for osteoarthritis: a prospective study of 6682 patients from linked national datasets in England. Bmj Open, 11, e046712. http://doi.org/10.1136/bmjopen-2020-046712
Ferguson, R., Prieto-Alhambra, D., Peat, G., Delmestri, A., Jordan, K. P., . Y. Strauss, V., et al. (2021). Does pre-existing morbidity influences risks and benefits of total hip replacement for osteoarthritis: a prospective study of 6682 patients from linked national datasets in England. Bmj Open, 11, e046712. http://doi.org/10.1136/bmjopen-2020-046712